Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2006

Study Completion Date

February 28, 2006

Conditions

Healthy

Interventions

DRUG

Oxybutynin Chloride Extended-Release Tablets, 15 mg

15mg, single dose fasting

DRUG

Ditropan XL® Extended-release tablets, 15 mg

15mg, single dose fasting

Trial Locations (1)

PRACS Institute Ltd. - Cetero Research, Fargo